Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06378476 · ClinicalTrials.gov registry record · NA
Supportive Understanding and Patient-centered Partnership for Optimizing Renal Treatment
A NA study of Chronic Kidney Diseases and Trauma, Psychological, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 153
- Enrollment target
- 1
- Study location
NCT06378476 is a NA study of Chronic Kidney Diseases and Trauma, Psychological that has completed, run by University of Pennsylvania. The registered enrollment target is 153 participants, below the 443-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06378476, a NA study of Chronic Kidney Diseases and Trauma, Psychological, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 153 participants
- Enrollment target
- 1
- Study location
Study Summary
Black and Hispanic people face higher risks of chronic kidney disease (CKD) but have unequal access to the highest-quality kidney care. Black adults with CKD face 1.5 times higher hospitalization risks than non-Black adults with CKD. Once reaching end stage kidney disease (ESKD), Black patients are half as likely to receive a transplant and are often excluded from home dialysis. Structural racism creates complex barriers to optimal CKD care, providing an explanation for these findings. The Penn Medicine IMPaCT Community Health Worker (CHW) program is a rigorously tested approach to employ people from local communities to dismantle structural racism within health care systems and improve outcomes for marginalized patients. This trial will innovate by training CHWs to focus specifically on CKD care for minoritized people. The investigators will also train primary care clinicians caring for CKD patients on how to provide trauma-informed care (TIC). The first aim is to determine the feasibility, acceptability, and reach of a clinic-level TIC training to address the needs and concerns of Black and other minoritized patients. The second aim will be to conduct a three arm trial comparing individuals in usual care to individuals randomized to either our tailored CHW intervention in conjunction with clinic-level TIC training or to clinic-level TIC intervention only. The investigators will examine whether patients in the intervention arms have greater improvements in quality of life (primary). The investigators will also explore the impact of the interventions on patient activation, hospitalizations, and ESKD treatment preferences.
Conditions Studied
Interventions
- BEHAVIORAL IMPaCT Community Health Worker Program
- OTHER Trauma-Informed Care Training
Study Locations (1)
Pennsylvania
- Penn Medicine - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 153 participants |
| Start Date | 2024-06-17 |
| Est. Completion | 2025-11-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06378476
The ClinicalTrials.gov registry entry for NCT06378476 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 153 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 443-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (65% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Chronic Kidney Diseases appearing as the primary indexed condition, and to 2 interventions - of which IMPaCT Community Health Worker Program is the first listed.
NCT06378476 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06378476 about?
NCT06378476 is a clinical study titled "Supportive Understanding and Patient-centered Partnership for Optimizing Renal Treatment". Black and Hispanic people face higher risks of chronic kidney disease (CKD) but have unequal access to the highest-quality kidney care. Black adults with CKD face 1.5 times higher hospitalization risks than non-Black adults with CKD. Once reaching end stage kidney disease (ESKD), Black patients are ...
What is the current status of trial NCT06378476?
This trial is currently completed. It is a NA study. The enrollment target is 153 participants. The study started on 2024-06-17. Estimated completion is 2025-11-26.
What conditions does trial NCT06378476 study?
This clinical trial studies the following conditions: Chronic Kidney Diseases, Trauma, Psychological, Racism, Systemic.
What interventions are being tested in trial NCT06378476?
The interventions under investigation include: IMPaCT Community Health Worker Program (BEHAVIORAL), Trauma-Informed Care Training (OTHER).
Who is sponsoring clinical trial NCT06378476?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06378476 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Kidney Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
RECRUITING · NA
-
Mindfulness in Chronic Kidney Disease
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
RECRUITING · NA
-
Improving the Collaborative Health of Minority COVID-19 Survivor and Carepartner Dyads
RECRUITING · NA
-
Handgrip Exercise Training and CKD
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.